Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients

Am J Hematol. 2023 Feb;98(2):E28-E31. doi: 10.1002/ajh.26786. Epub 2022 Dec 1.

Authors

Abhishek A Mangaonkar¹, Kimberly J Langer¹, Terra L Lasho¹, Christy Finke¹, Mark R Litzow¹, William J Hogan¹, Mithun V Shah¹, Ronald S Go¹, Gabriel Bartoo¹, Jade Kutzke¹, Kristen B McCullough¹, Matthew Koster², Matthew Samec², Kenneth J Warrington², Kaaren K Reichard³, Horatiu Olteanu³, Mary Riwes⁴, Mrinal M Patnaik¹, Hassan B Alkhateeb¹

Affiliations

¹ Dvision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Dvision of Hematopathology, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA.

PMID: 36403135
DOI: 10.1002/ajh.26786

No abstract available

Publication types

Letter

MeSH terms

Graft vs Host Disease* / etiology
Graft vs Host Disease* / prevention & control
Hematopoietic Stem Cell Transplantation*
Humans
Myelodysplastic Syndromes*
Transplantation Conditioning

Supplementary concepts

VEXAS syndrome